Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Hu

Showing results (161-170 of 267) with videos related to

Pageof 27
Sort By:
BMC Surgery|November 22, 2019
Evaluation of D2-plus radical resection for gastric cancer with pyloric invasionZhi-Yuan Xu, Can Hu, Shangqi Chen, et al.
International Heart Journal|May 1, 2020
A Novel Laboratory-Based Model to Predict the Presence of Obstructive Coronary Artery DiseaseLing-Yun Zhou, Wen-Jun Yin, Jiang-Lin Wang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2018
Utility of cystatin C-based equations in patients undergoing dialysisDai-Yang Li, Wen-Jun Yin, Ling-Yun Zhou, et al.
Acta Pharmacologica Sinica|July 23, 2020
Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in miceXin Zhang, Can Hu, Ning Zhang, et al.
Journal of Infection in Developing Countries|April 11, 2021
Epidemiologic Characteristics of COVID-19 in Guizhou Province, ChinaKaike Ping, Mingyu Lei, Yun Gou, et al.
Urology Case Reports|October 23, 2023
Exophytic benign prostatic hyperplasia presenting as a polycystic pelvic massShuang Xu, Tao Guo, Jianglei Zhang, et al.
Forensic Science International|November 30, 2025
Origin traceability of Amur tiger hair using stable isotope ratio mass spectrometryLin Feng, Chenjie Wei, Xianhe Deng, et al.
Cancer Immunology, Immunotherapy : CII|September 10, 2025
Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort studyXingmao Huang, Xiangliu Chen, Jiahui Chen, et al.
World Journal of Gastrointestinal Oncology|April 25, 2024
Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancersZhe-Han Bao, Can Hu, Yan-Qiang Zhang, et al.
Journal of Cellular and Molecular Medicine|February 14, 2020
Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transitionXiaofeng Wang, Zhiyuan Xu, Jiancheng Sun, et al.
Pageof 27

Showing results (161-170 of 267) with videos related to

Sort By:
Pageof 27
BMC Surgery|November 22, 2019
Evaluation of D2-plus radical resection for gastric cancer with pyloric invasionZhi-Yuan Xu, Can Hu, Shangqi Chen, et al.
International Heart Journal|May 1, 2020
A Novel Laboratory-Based Model to Predict the Presence of Obstructive Coronary Artery DiseaseLing-Yun Zhou, Wen-Jun Yin, Jiang-Lin Wang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2018
Utility of cystatin C-based equations in patients undergoing dialysisDai-Yang Li, Wen-Jun Yin, Ling-Yun Zhou, et al.
Acta Pharmacologica Sinica|July 23, 2020
Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in miceXin Zhang, Can Hu, Ning Zhang, et al.
Journal of Infection in Developing Countries|April 11, 2021
Epidemiologic Characteristics of COVID-19 in Guizhou Province, ChinaKaike Ping, Mingyu Lei, Yun Gou, et al.
Urology Case Reports|October 23, 2023
Exophytic benign prostatic hyperplasia presenting as a polycystic pelvic massShuang Xu, Tao Guo, Jianglei Zhang, et al.
Forensic Science International|November 30, 2025
Origin traceability of Amur tiger hair using stable isotope ratio mass spectrometryLin Feng, Chenjie Wei, Xianhe Deng, et al.
Cancer Immunology, Immunotherapy : CII|September 10, 2025
Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort studyXingmao Huang, Xiangliu Chen, Jiahui Chen, et al.
World Journal of Gastrointestinal Oncology|April 25, 2024
Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancersZhe-Han Bao, Can Hu, Yan-Qiang Zhang, et al.
Journal of Cellular and Molecular Medicine|February 14, 2020
Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transitionXiaofeng Wang, Zhiyuan Xu, Jiancheng Sun, et al.
Pageof 27